Share on StockTwits

Acadia Healthcare Company (NASDAQ:ACHC) Director William Grieco sold 4,522 shares of the company’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $50.67, for a total transaction of $229,129.74. Following the completion of the transaction, the director now directly owns 29,762 shares of the company’s stock, valued at approximately $1,508,041. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

A number of analysts have recently weighed in on ACHC shares. Analysts at Zacks downgraded shares of Acadia Healthcare Company from an “outperform” rating to a “neutral” rating in a research note on Tuesday, August 5th. They now have a $53.00 price target on the stock. Separately, analysts at RBC Capital raised their price target on shares of Acadia Healthcare Company from $54.00 to $58.00 in a research note on Friday, August 1st. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Acadia Healthcare Company from $57.00 to $60.00 in a research note on Thursday, July 31st. They now have a “buy” rating on the stock. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $53.57.

Acadia Healthcare Company (NASDAQ:ACHC) traded up 1.33% during mid-day trading on Wednesday, hitting $51.98. 337,116 shares of the company’s stock traded hands. Acadia Healthcare Company has a 52-week low of $36.92 and a 52-week high of $53.87. The stock’s 50-day moving average is $47.87 and its 200-day moving average is $46.2. The company has a market cap of $3.109 billion and a P/E ratio of 42.19.

Acadia Healthcare Company (NASDAQ:ACHC) last released its earnings data on Tuesday, July 29th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.01. The company had revenue of $213.80 million for the quarter, compared to the consensus estimate of $207.73 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. On average, analysts predict that Acadia Healthcare Company will post $1.46 earnings per share for the current fiscal year.

Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.